tiprankstipranks
Trending News
More News >

Merck KGaA confirms late-stage talks to acquire SpringWorks for $47 per share

Merck KGaA (MKGAY) reacted to press reports and confirmed late-stage discussions with SpringWorks Therapeutics (SWTX) on a potential acquisition. The parties are in discussion on the basis of a price of around $47 per share. Merck noted that no final decision has been taken and no legally binding agreement has been entered into.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue